T1	Outcomes 460 468	efficacy
T2	Outcomes 473 479	safety
T3	Outcomes 740 778	baseline median plasma HIV-1 RNA level
T4	Outcomes 1053 1075	plasma HIV-1 RNA level
T5	Outcomes 1218 1235	virologic failure
T6	Outcomes 1250 1317	emergence of resistance mutations, CD4 cell increases from baseline
T7	Outcomes 1350 1365	safety profile,
T8	Outcomes 1370 1421	incidence of ABC-related hypersensitivity reactions